Today we are delighted to announce the further expansion of our collaboration with Lilly. Lilly is a leader in innovative RNA science, making them a great partner for our Axiomer technology.
… ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview ProQR Management … the announcement of the expansion of ProQR and Lilly's partnership, ProQR Management is hosting a conference call. …
In June we caught up with our Lead Talent Acquisition, Silvia Catellani, to talk about ProQR, Pride, and driving an inclusive culture for present and future ProQRians.
Partnerships in our industry are very common as companies look to benefit from knowledge and resource sharing. In this blog we explore why companies, like ProQR, partner with other companies.
… Fong, PhD, Head of Company Creation at RTW, said: “Our partnership with ProQR fits perfectly into Yarrow’s mission … diseases. We look forward to a long and productive partnership.” Daniel A. De Boer, Founder and CEO of ProQR, …
… Trust Join Forces with Axiomer™ RNA Editing Collaboration Partnership focused on utilizing Axiomer ™ to develop editing … and MECP2 protein recovery. It is the intent of the partnership to be continued by an expanded co-funding …
… lives of patients across a spectrum of diseases.” “This partnership with Lilly, a leader in RNA therapeutics, is an … A. de Boer, Founder and CEO of ProQR. “Additionally, this partnership further strengthens our financial position.” …
